MYCOPHENILIC ACID

MYCOPHENILIC ACID was reported 21363 times

These side effects are most commonly reported by patients taking MYCOPHENILIC ACID:

# Side effect Count
0 OFF LABEL USE 2300
1 DRUG INEFFECTIVE 1556
2 DIARRHOEA 1110
3 ACUTE KIDNEY INJURY 922
4 COVID-19 805
5 NAUSEA 803
6 PRODUCT USE IN UNAPPROVED INDICATION 773
7 PYREXIA 766
8 DRUG INTERACTION 736
9 DEATH 723
10 FATIGUE 693
11 HEADACHE 650
12 PNEUMONIA 628
13 DYSPNOEA 621
14 CYTOMEGALOVIRUS INFECTION 613
15 VOMITING 585
16 SEPSIS 562
17 CONDITION AGGRAVATED 539
18 RENAL IMPAIRMENT 483
19 TRANSPLANT REJECTION 475
20 COUGH 452
21 ABDOMINAL PAIN 447
22 TOXICITY TO VARIOUS AGENTS 424
23 ASTHENIA 422
24 URINARY TRACT INFECTION 419
25 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 399
26 RESPIRATORY FAILURE 399
27 NEUTROPENIA 385
28 DIZZINESS 366
29 ANAEMIA 362
30 ARTHRALGIA 360
31 SEPTIC SHOCK 359
32 KIDNEY TRANSPLANT REJECTION 355
33 MALAISE 347
34 LEUKOPENIA 343
35 INFECTION 341
36 MULTIPLE ORGAN DYSFUNCTION SYNDROME 338
37 BLOOD CREATININE INCREASED 328
38 WEIGHT DECREASED 316
39 ABDOMINAL PAIN UPPER 312
40 DECREASED APPETITE 306
41 FALL 298
42 RENAL FAILURE 286
43 BLOOD PRESSURE INCREASED 280
44 PRURITUS 279
45 CHILLS 277
46 SOMNOLENCE 267
47 GASTROINTESTINAL DISORDER 263
48 PAIN 261
49 CYTOMEGALOVIRUS VIRAEMIA 259
50 HAEMATURIA 255
51 PANCYTOPENIA 252
52 TACHYCARDIA 252
53 MYALGIA 247
54 HYPERTENSION 245
55 INSOMNIA 236
56 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 234
57 THROMBOCYTOPENIA 234
58 PRODUCT DOSE OMISSION ISSUE 233
59 HYPOTENSION 224
60 RASH 223
61 COMA 221
62 DRUG INTOLERANCE 221
63 THROMBOTIC MICROANGIOPATHY 218
64 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 216
65 HOSPITALISATION 211
66 TREATMENT FAILURE 211
67 VISION BLURRED 209
68 BRONCHOPULMONARY ASPERGILLOSIS 201
69 DISEASE RECURRENCE 201
70 DISEASE PROGRESSION 197
71 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 195
72 ASPERGILLUS INFECTION 189
73 COMPLICATIONS OF TRANSPLANTED KIDNEY 189
74 ASCITES 188
75 CHRONIC KIDNEY DISEASE 186
76 BK VIRUS INFECTION 183
77 ACUTE RESPIRATORY DISTRESS SYNDROME 180
78 DRUG LEVEL INCREASED 180
79 EPSTEIN-BARR VIRUS INFECTION 180
80 PROTEINURIA 178
81 TREMOR 178
82 ABDOMINAL DISCOMFORT 176
83 EYE PAIN 173
84 SYNCOPE 173
85 BLINDNESS 171
86 WEIGHT INCREASED 171
87 PNEUMOCYSTIS JIROVECII PNEUMONIA 169
88 MATERNAL EXPOSURE DURING PREGNANCY 168
89 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 167
90 PSEUDOMONAS INFECTION 167
91 DEHYDRATION 166
92 GENERALISED OEDEMA 166
93 PRODUCT USE ISSUE 165
94 PERIPHERAL SWELLING 163
95 HYPERKALAEMIA 162
96 CARDIO-RESPIRATORY ARREST 159
97 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 159
98 DIPLOPIA 156
99 NOCARDIOSIS 155
100 PLEURAL EFFUSION 154
101 HAEMATEMESIS 153
102 NEPHROPATHY TOXIC 153
103 ENTEROCOCCAL INFECTION 152
104 ALTERED STATE OF CONSCIOUSNESS 151
105 CARDIAC ARREST 150
106 HAEMORRHAGIC STROKE 150
107 THERAPY INTERRUPTED 150
108 PAIN IN EXTREMITY 148
109 GENERAL PHYSICAL HEALTH DETERIORATION 147
110 HEAD DISCOMFORT 147
111 PHOTOPHOBIA 146
112 PRESYNCOPE 145
113 TINNITUS 145
114 OCULAR DISCOMFORT 143
115 THERAPY NON-RESPONDER 143
116 ACUTE RESPIRATORY FAILURE 142
117 SYSTEMIC LUPUS ERYTHEMATOSUS 139
118 HAEMOGLOBIN DECREASED 138
119 OEDEMA PERIPHERAL 138
120 URINARY TRACT DISORDER 138
121 ENCEPHALOPATHY 137
122 CANDIDA INFECTION 135
123 AMAUROSIS FUGAX 134
124 INTENTIONAL PRODUCT USE ISSUE 133
125 DIABETES MELLITUS 132
126 INFLUENZA 131
127 INTERSTITIAL LUNG DISEASE 131
128 CRYPTOCOCCOSIS 129
129 ESCHERICHIA INFECTION 129
130 KAPOSI^S SARCOMA 129
131 POLYOMAVIRUS VIRAEMIA 129
132 COVID-19 PNEUMONIA 126
133 DRUG RESISTANCE 125
134 END STAGE RENAL DISEASE 124
135 FUNGAL INFECTION 123
136 FEBRILE NEUTROPENIA 122
137 KLEBSIELLA INFECTION 121
138 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 120
139 BACK PAIN 119
140 NASOPHARYNGITIS 119
141 STAPHYLOCOCCAL INFECTION 119
142 CHEST PAIN 118
143 METABOLIC ACIDOSIS 118
144 COLITIS 117
145 RENAL TUBULAR NECROSIS 116
146 TREATMENT NONCOMPLIANCE 116
147 MUSCULAR WEAKNESS 113
148 MUCORMYCOSIS 109
149 BACTERAEMIA 107
150 BACTERIAL INFECTION 106
151 GASTROOESOPHAGEAL REFLUX DISEASE 106
152 TRANSPLANT DYSFUNCTION 106
153 HERPES ZOSTER 105
154 SEIZURE 105
155 ATRIAL FIBRILLATION 104
156 HYPOXIA 104
157 LYMPHOPENIA 104
158 PULMONARY NOCARDIOSIS 104
159 GRAFT VERSUS HOST DISEASE 103
160 MALACOPLAKIA 103
161 BRAIN ABSCESS 102
162 CARDIAC FAILURE 102
163 ALOPECIA 101
164 CEREBROVASCULAR ACCIDENT 101
165 RESPIRATORY DISTRESS 101
166 SINUSITIS 101
167 JOINT SWELLING 100
168 GASTROINTESTINAL HAEMORRHAGE 99
169 HYPOGAMMAGLOBULINAEMIA 99
170 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 96
171 TUBULOINTERSTITIAL NEPHRITIS 96
172 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 95
173 ANXIETY 94
174 DIFFUSE LARGE B-CELL LYMPHOMA 94
175 GAIT DISTURBANCE 94
176 HYPONATRAEMIA 94
177 CONFUSIONAL STATE 93
178 CONSTIPATION 93
179 CYTOMEGALOVIRUS COLITIS 93
180 HISTOPLASMOSIS DISSEMINATED 93
181 PYELONEPHRITIS 93
182 TRANSPLANT FAILURE 93
183 GRAFT VERSUS HOST DISEASE IN SKIN 92
184 FEELING ABNORMAL 91
185 HYPERGLYCAEMIA 91
186 RENAL TRANSPLANT FAILURE 91
187 LOSS OF CONSCIOUSNESS 90
188 NEUROTOXICITY 90
189 ABDOMINAL DISTENSION 89
190 ACUTE GRAFT VERSUS HOST DISEASE 89
191 CYTOMEGALOVIRUS INFECTION REACTIVATION 89
192 DRUG HYPERSENSITIVITY 89
193 HEPATITIS E 88
194 DISSEMINATED CRYPTOCOCCOSIS 86
195 DIVERTICULITIS 86
196 INFLAMMATION 86
197 SHOCK 86
198 HAEMORRHAGE 85
199 LUNG DISORDER 84
200 PULMONARY EMBOLISM 84
201 DYSPHAGIA 83
202 LUPUS NEPHRITIS 83
203 BLOOD GLUCOSE INCREASED 82
204 ILLNESS 82
205 OSTEOPOROSIS 82
206 PLATELET COUNT DECREASED 82
207 PRODUCTIVE COUGH 82
208 RENAL DISORDER 82
209 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 82
210 JC VIRUS INFECTION 81
211 OXYGEN SATURATION DECREASED 81
212 PULMONARY OEDEMA 81
213 UPPER RESPIRATORY TRACT INFECTION 81
214 PARVOVIRUS B19 INFECTION 80
215 WHITE BLOOD CELL COUNT DECREASED 80
216 ADENOVIRUS INFECTION 79
217 CELLULITIS 79
218 MENTAL STATUS CHANGES 79
219 VIRAL INFECTION 79
220 MENINGITIS CRYPTOCOCCAL 78
221 SWELLING 78
222 WEST NILE VIRAL INFECTION 78
223 DYSPEPSIA 77
224 MUSCLE SPASMS 77
225 NO ADVERSE EVENT 77
226 PATHOGEN RESISTANCE 77
227 CLOSTRIDIUM DIFFICILE INFECTION 76
228 DEPRESSION 76
229 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 76
230 KIDNEY FIBROSIS 76
231 NEUROPATHY PERIPHERAL 76
232 CATARACT 75
233 HEART RATE INCREASED 75
234 HEPATIC FAILURE 75
235 HERPES SIMPLEX 75
236 HYPERSENSITIVITY 74
237 CHRONIC ALLOGRAFT NEPHROPATHY 73
238 HEPATIC ENZYME INCREASED 73
239 MYOCARDIAL INFARCTION 73
240 C-REACTIVE PROTEIN INCREASED 72
241 CHEST DISCOMFORT 72
242 CYSTITIS HAEMORRHAGIC 71
243 LEUKOCYTOSIS 71
244 FLUID RETENTION 70
245 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 70
246 INFUSION RELATED REACTION 70
247 STRONGYLOIDIASIS 70
248 SKIN LESION 69
249 THERAPEUTIC RESPONSE DECREASED 69
250 THROMBOSIS 69
251 DISSEMINATED TUBERCULOSIS 68
252 ERYTHEMA 68
253 OROPHARYNGEAL PAIN 68
254 UROSEPSIS 68
255 HYDRONEPHROSIS 67
256 HYPOAESTHESIA 67
257 INFECTION REACTIVATION 67
258 MOUTH ULCERATION 67
259 PARAESTHESIA 67
260 PNEUMONITIS 67
261 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 66
262 DYSPNOEA EXERTIONAL 66
263 HEPATOTOXICITY 66
264 MUCOSAL INFLAMMATION 66
265 SURGERY 66
266 VARICELLA ZOSTER VIRUS INFECTION 66
267 LACTIC ACIDOSIS 65
268 MYASTHENIA GRAVIS 65
269 PNEUMONIA ASPIRATION 65
270 SQUAMOUS CELL CARCINOMA OF SKIN 65
271 CHRONIC GRAFT VERSUS HOST DISEASE 64
272 ENCEPHALITIS 64
273 LIVER TRANSPLANT REJECTION 64
274 OEDEMA 64
275 RENAL TRANSPLANT 64
276 ABORTION SPONTANEOUS 63
277 CLOSTRIDIUM DIFFICILE COLITIS 63
278 HYPOKALAEMIA 63
279 HEART TRANSPLANT REJECTION 62
280 URTICARIA 62
281 CARDIAC DISORDER 61
282 DELAYED GRAFT FUNCTION 61
283 DRUG-INDUCED LIVER INJURY 61
284 LYMPHADENOPATHY 61
285 APLASIA PURE RED CELL 60
286 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 60
287 OESOPHAGEAL ULCER 60
288 VISUAL IMPAIRMENT 60
289 CEREBRAL INFARCTION 59
290 PNEUMONIA CRYPTOCOCCAL 59
291 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 58
292 EPSTEIN-BARR VIRAEMIA 57
293 EXPOSURE DURING PREGNANCY 57
294 HAEMATOMA 57
295 PERICARDIAL EFFUSION 57
296 PNEUMONIA CYTOMEGALOVIRAL 57
297 SQUAMOUS CELL CARCINOMA 57
298 ARTHRITIS 56
299 DEEP VEIN THROMBOSIS 56
300 DELIRIUM 56
301 DISSEMINATED INTRAVASCULAR COAGULATION 56
302 ELECTROLYTE IMBALANCE 56
303 HUMAN HERPESVIRUS 6 INFECTION 56
304 ISCHAEMIC STROKE 56
305 PULMONARY MASS 56
306 RESPIRATORY TRACT INFECTION 56
307 ADVERSE DRUG REACTION 55
308 BRONCHITIS 55
309 CYTOPENIA 55
310 DYSURIA 55
311 GOUT 55
312 HISTOPLASMOSIS 55
313 RHEUMATOID ARTHRITIS 55
314 TRANSAMINASES INCREASED 55
315 ALANINE AMINOTRANSFERASE INCREASED 54
316 B-CELL LYMPHOMA 54
317 BONE MARROW FAILURE 54
318 PALPITATIONS 54
319 PNEUMONIA FUNGAL 54
320 BLASTOMYCOSIS 53
321 EPISTAXIS 53
322 HYPERCALCAEMIA 53
323 INJECTION SITE PAIN 53
324 NEPHROPATHY 53
325 NEPHROTIC SYNDROME 53
326 PULMONARY FIBROSIS 53
327 CONTUSION 52
328 CROHN^S DISEASE 52
329 DISSEMINATED MUCORMYCOSIS 52
330 MOBILITY DECREASED 52
331 OSTEOMYELITIS 52
332 POSTOPERATIVE WOUND INFECTION 51
333 RHINORRHOEA 51
334 THERAPY CESSATION 51
335 MUSCULOSKELETAL STIFFNESS 50
336 HAEMOLYTIC ANAEMIA 49
337 HEART FAILURE WITH PRESERVED EJECTION FRACTION 49
338 INCORRECT DOSE ADMINISTERED 49
339 ORGANISING PNEUMONIA 49
340 UNDERDOSE 49
341 GASTRITIS 48
342 GENERALISED TONIC-CLONIC SEIZURE 48
343 MEMORY IMPAIRMENT 48
344 PANCREATITIS 48
345 PNEUMONIA BACTERIAL 48
346 LIVER DISORDER 47
347 PANCREATITIS ACUTE 47
348 RASH ERYTHEMATOUS 47
349 RENAL TUBULAR ATROPHY 47
350 SKIN ULCER 47
351 ACUTE HEPATIC FAILURE 46
352 DRUG LEVEL ABOVE THERAPEUTIC 46
353 MALIGNANT MELANOMA 46
354 RENAL FAILURE ACUTE 46
355 HAEMODYNAMIC INSTABILITY 45
356 HEMIPARESIS 45
357 IMPAIRED HEALING 45
358 KIDNEY INFECTION 45
359 MIGRAINE 45
360 PHAEOHYPHOMYCOSIS 45
361 PNEUMOTHORAX 45
362 PULMONARY ALVEOLAR HAEMORRHAGE 45
363 SCEDOSPORIUM INFECTION 45
364 SWELLING FACE 45
365 TUBERCULOSIS 45
366 BRADYCARDIA 44
367 DRY MOUTH 44
368 ENTEROBACTER INFECTION 44
369 NEOPLASM MALIGNANT 44
370 PERITONITIS 44
371 WHEEZING 44
372 ABSCESS 43
373 BASAL CELL CARCINOMA 43
374 BLOOD PRESSURE DECREASED 43
375 CENTRAL NERVOUS SYSTEM LUPUS 43
376 CYSTITIS 43
377 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 43
378 HAEMOPTYSIS 43
379 HYPOMAGNESAEMIA 43
380 MYELOSUPPRESSION 43
381 OVERDOSE 43
382 PAPILLOMA VIRAL INFECTION 43
383 PSORIASIS 43
384 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 42
385 CONTRAINDICATED PRODUCT ADMINISTERED 42
386 DISCOMFORT 42
387 GLOMERULAR FILTRATION RATE DECREASED 42
388 SEROSITIS 42
389 ANAPHYLACTIC REACTION 41
390 BRONCHIECTASIS 41
391 CENTRAL NERVOUS SYSTEM LYMPHOMA 41
392 DIALYSIS 41
393 ESCHERICHIA URINARY TRACT INFECTION 41
394 FOETAL EXPOSURE DURING PREGNANCY 41
395 GASTROENTERITIS 41
396 HYPERVOLAEMIA 41
397 IMMUNOSUPPRESSION 41
398 MYOSITIS 41
399 PULMONARY HYPERTENSION 41
400 THERAPY PARTIAL RESPONDER 41
401 TRICHODYSPLASIA SPINULOSA 41
402 AGRANULOCYTOSIS 40
403 APOPTOSIS 40
404 BRAIN OEDEMA 40
405 CEREBRAL HAEMORRHAGE 40
406 CYTOKINE RELEASE SYNDROME 40
407 DIABETIC KETOACIDOSIS 40
408 INTENTIONAL DOSE OMISSION 40
409 LIVER INJURY 40
410 NASAL CONGESTION 40
411 PNEUMONIA PSEUDOMONAL 40
412 PREMATURE DELIVERY 40
413 STOMATITIS 40
414 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40
415 BACTERIAL SEPSIS 39
416 COLITIS ULCERATIVE 39
417 DISTRIBUTIVE SHOCK 39
418 ENCEPHALITIS VIRAL 39
419 HAEMATOCHEZIA 39
420 LOWER RESPIRATORY TRACT INFECTION 39
421 MULTI-ORGAN FAILURE 39
422 OESOPHAGITIS 39
423 SLEEP DISORDER 39
424 UNEVALUABLE EVENT 39
425 VENOOCCLUSIVE LIVER DISEASE 39
426 ASTHMA 38
427 ATELECTASIS 38
428 BODY MASS INDEX ABNORMAL 38
429 GASTRIC ULCER 38
430 INFLUENZA LIKE ILLNESS 38
431 NIGHT SWEATS 38
432 PSORIATIC ARTHROPATHY 38
433 SHOCK HAEMORRHAGIC 38
434 SKIN INFECTION 38
435 SYNOVITIS 38
436 CEREBRAL NOCARDIOSIS 37
437 DEPRESSED LEVEL OF CONSCIOUSNESS 37
438 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 37
439 HEPATIC FUNCTION ABNORMAL 37
440 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 37
441 LIVER FUNCTION TEST ABNORMAL 37
442 MUSCULOSKELETAL PAIN 37
443 OSTEONECROSIS 37
444 PULMONARY MUCORMYCOSIS 37
445 RENAL TUBULAR INJURY 37
446 RHINOVIRUS INFECTION 37
447 CEREBRAL TOXOPLASMOSIS 36
448 GLOMERULONEPHRITIS 36
449 HYPOPHAGIA 36
450 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36
451 INFLAMMATORY BOWEL DISEASE 36
452 INTESTINAL OBSTRUCTION 36
453 MONKEYPOX 36
454 MYOPATHY 36
455 PERICARDITIS 36
456 ARTHROPATHY 35
457 ASPARTATE AMINOTRANSFERASE INCREASED 35
458 BLOOD PRESSURE FLUCTUATION 35
459 BLOOD SODIUM DECREASED 35
460 CAT SCRATCH DISEASE 35
461 CHOLANGITIS 35
462 DISORIENTATION 35
463 DRY SKIN 35
464 HEPATITIS C 35
465 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 35
466 LETHARGY 35
467 PYELONEPHRITIS ACUTE 35
468 REBOUND EFFECT 35
469 THROAT IRRITATION 35
470 URINARY RETENTION 35
471 VIRAEMIA 35
472 ADVERSE EVENT 34
473 APHASIA 34
474 BLOOD UREA INCREASED 34
475 COAGULOPATHY 34
476 CRYPTOSPORIDIOSIS INFECTION 34
477 DEPRESSED MOOD 34
478 DYSPHONIA 34
479 GRAFT VERSUS HOST DISEASE IN LIVER 34
480 HYPERHIDROSIS 34
481 LARGE INTESTINE PERFORATION 34
482 NECK PAIN 34
483 NEPHROLITHIASIS 34
484 RED BLOOD CELL SEDIMENTATION RATE INCREASED 34
485 BLISTER 33
486 BLOOD BILIRUBIN INCREASED 33
487 CARDIAC FAILURE CONGESTIVE 33
488 CYTOMEGALOVIRUS CHORIORETINITIS 33
489 FLUSHING 33
490 HEPATIC ENCEPHALOPATHY 33
491 ILL-DEFINED DISORDER 33
492 INFUSION SITE PAIN 33
493 LUNG INFECTION 33
494 OLIGURIA 33
495 PRODUCT DOSE OMISSION IN ERROR 33
496 UPPER GASTROINTESTINAL HAEMORRHAGE 33
497 WOUND INFECTION 33
498 ALTERNARIA INFECTION 32
499 CARDIOGENIC SHOCK 32
500 DEVICE RELATED INFECTION 32
501 GASTROENTERITIS NOROVIRUS 32
502 HAEMATOLOGICAL INFECTION 32
503 HAEMORRHOIDS 32
504 HEPATITIS 32
505 LUNG TRANSPLANT REJECTION 32
506 METASTASES TO LYMPH NODES 32
507 MYOCARDITIS 32
508 OESOPHAGEAL CANDIDIASIS 32
509 ORAL HERPES 32
510 RENAL INJURY 32
511 SMALL INTESTINAL OBSTRUCTION 32
512 VISCERAL LEISHMANIASIS 32
513 AZOTAEMIA 31
514 CHOLESTASIS 31
515 DRUG LEVEL DECREASED 31
516 EMOTIONAL DISTRESS 31
517 ENDOCARDITIS 31
518 ESCHERICHIA SEPSIS 31
519 IRON DEFICIENCY ANAEMIA 31
520 OESOPHAGEAL STENOSIS 31
521 PREMATURE BABY 31
522 RESPIRATORY SYNCYTIAL VIRUS INFECTION 31
523 SKIN CANCER 31
524 SKIN NECROSIS 31
525 ULCER 31
526 ABDOMINAL PAIN LOWER 30
527 BALANCE DISORDER 30
528 BLOOD CHOLESTEROL INCREASED 30
529 BLOOD LACTATE DEHYDROGENASE INCREASED 30
530 DERMATITIS 30
531 DUODENAL ULCER 30
532 ESCHERICHIA BACTERAEMIA 30
533 GRAFT LOSS 30
534 GRANULOMA 30
535 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 30
536 LOCALISED INFECTION 30
537 MYCOBACTERIAL INFECTION 30
538 NEPHROGENIC ANAEMIA 30
539 OSTEOPENIA 30
540 RASH PRURITIC 30
541 STRESS 30
542 THERAPY CHANGE 30
543 TRANSIENT ISCHAEMIC ATTACK 30
544 TRANSITIONAL CELL CARCINOMA 30
545 URINARY TRACT INFECTION BACTERIAL 30
546 ACINETOBACTER INFECTION 29
547 BURNING SENSATION 29
548 CALCIPHYLAXIS 29
549 CORONAVIRUS INFECTION 29
550 FLATULENCE 29
551 GAIT INABILITY 29
552 HEPATIC CIRRHOSIS 29
553 HEPATIC FIBROSIS 29
554 HYPOPHOSPHATAEMIA 29
555 INTRACRANIAL PRESSURE INCREASED 29
556 LARGE INTESTINAL ULCER 29
557 METASTASES TO LIVER 29
558 NERVOUS SYSTEM DISORDER 29
559 NOROVIRUS INFECTION 29
560 RESPIRATORY DISORDER 29
561 SPEECH DISORDER 29
562 STAPHYLOCOCCAL BACTERAEMIA 29
563 UVEITIS 29
564 ANURIA 28
565 ARRHYTHMIA 28
566 ARTERIOSCLEROSIS 28
567 BONE EROSION 28
568 COGNITIVE DISORDER 28
569 ENTERITIS 28
570 FEELING HOT 28
571 FUNGAL SKIN INFECTION 28
572 HAEMOLYTIC URAEMIC SYNDROME 28
573 HEPATITIS CHOLESTATIC 28
574 HYPERPARATHYROIDISM SECONDARY 28
575 HYPOVOLAEMIA 28
576 LUNG INFILTRATION 28
577 PEMPHIGUS 28
578 RECTAL HAEMORRHAGE 28
579 SCLERODERMA 28
580 SKIN DISCOLOURATION 28
581 TACHYPNOEA 28
582 THERAPEUTIC PRODUCT EFFECT DECREASED 28
583 AGITATION 27
584 ANGIOEDEMA 27
585 ANOGENITAL WARTS 27
586 BRAIN HERNIATION 27
587 CENTRAL NERVOUS SYSTEM LESION 27
588 CUSHINGOID 27
589 CYSTITIS VIRAL 27
590 DYSGEUSIA 27
591 GINGIVAL HYPERTROPHY 27
592 HAEMOLYSIS 27
593 HALLUCINATION, VISUAL 27
594 HEPATIC NECROSIS 27
595 LOWER GASTROINTESTINAL HAEMORRHAGE 27
596 METASTASES TO LUNG 27
597 PNEUMATOSIS INTESTINALIS 27
598 PNEUMONIA VIRAL 27
599 QUALITY OF LIFE DECREASED 27
600 STENOTROPHOMONAS INFECTION 27
601 SUICIDE ATTEMPT 27
602 UNRESPONSIVE TO STIMULI 27
603 UREAPLASMA INFECTION 27
604 VASCULITIS 27
605 ACIDOSIS 26
606 ANGINA PECTORIS 26
607 BLOOD POTASSIUM DECREASED 26
608 BLOOD PRESSURE SYSTOLIC INCREASED 26
609 DERMATITIS ATOPIC 26
610 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 26
611 ILEUS 26
612 IMMUNE SYSTEM DISORDER 26
613 LISTERIOSIS 26
614 ORAL CANDIDIASIS 26
615 PNEUMOPERITONEUM 26
616 RED BLOOD CELL COUNT DECREASED 26
617 SCIATICA 26
618 VERTIGO 26
619 BACILLARY ANGIOMATOSIS 25
620 BLOOD POTASSIUM INCREASED 25
621 CORONARY ARTERY DISEASE 25
622 CYTOMEGALOVIRUS OESOPHAGITIS 25
623 DISTURBANCE IN ATTENTION 25
624 FLUID OVERLOAD 25
625 JAUNDICE 25
626 LABORATORY TEST ABNORMAL 25
627 LIMB DISCOMFORT 25
628 LYMPHOCELE 25
629 MENINGITIS 25
630 MYCOBACTERIUM AVIUM COMPLEX INFECTION 25
631 OSTEOARTHRITIS 25
632 PANCREAS TRANSPLANT REJECTION 25
633 PLASMA CELL MYELOMA 25
634 POST PROCEDURAL COMPLICATION 25
635 PROTEIN URINE PRESENT 25
636 RENAL-LIMITED THROMBOTIC MICROANGIOPATHY 25
637 SYSTEMIC INFECTION 25
638 SYSTEMIC MYCOSIS 25
639 VACCINATION FAILURE 25
640 ACUTE MYOCARDIAL INFARCTION 24
641 AMNESIA 24
642 C-REACTIVE PROTEIN ABNORMAL 24
643 DISSEMINATED NOCARDIOSIS 24
644 ENTEROVIRUS INFECTION 24
645 EPILEPSY 24
646 GASTROENTERITIS VIRAL 24
647 HUMAN EHRLICHIOSIS 24
648 HYPERAMMONAEMIA 24
649 INFECTIOUS PLEURAL EFFUSION 24
650 INJECTION SITE BRUISING 24
651 LUNG CONSOLIDATION 24
652 PARALYSIS 24
653 PEMPHIGOID 24
654 POLLAKIURIA 24
655 PSYCHOTIC DISORDER 24
656 SKIN EXFOLIATION 24
657 THERAPEUTIC RESPONSE UNEXPECTED 24
658 ABNORMAL LOSS OF WEIGHT 23
659 ANGIOSARCOMA 23
660 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 23
661 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23
662 DUODENITIS 23
663 EMPYEMA 23
664 EOSINOPHILIA 23
665 GRAFT VERSUS HOST DISEASE IN LUNG 23
666 HALLUCINATION 23
667 HEPATITIS B REACTIVATION 23
668 HEPATOCELLULAR CARCINOMA 23
669 HERPES VIRUS INFECTION 23
670 HUMAN POLYOMAVIRUS INFECTION 23
671 INJURY 23
672 INTESTINAL PERFORATION 23
673 NECROTISING FASCIITIS 23
674 OBLITERATIVE BRONCHIOLITIS 23
675 PERITONITIS BACTERIAL 23
676 PNEUMONIA KLEBSIELLA 23
677 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 23
678 RASH MACULO-PAPULAR 23
679 SUPERINFECTION BACTERIAL 23
680 WHITE BLOOD CELL COUNT INCREASED 23
681 APLASTIC ANAEMIA 22
682 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 22
683 BLOOD ALKALINE PHOSPHATASE INCREASED 22
684 BLOOD URINE PRESENT 22
685 CHOLECYSTITIS 22
686 CYTOMEGALOVIRUS TEST POSITIVE 22
687 DIARRHOEA HAEMORRHAGIC 22
688 DISSEMINATED STRONGYLOIDIASIS 22
689 DYSARTHRIA 22
690 HERPES SIMPLEX HEPATITIS 22
691 HUMAN HERPESVIRUS 8 INFECTION 22
692 HYPOCALCAEMIA 22
693 LIMB INJURY 22
694 LIVER FUNCTION TEST INCREASED 22
695 LUNG NEOPLASM MALIGNANT 22
696 MELAENA 22
697 MITRAL VALVE INCOMPETENCE 22
698 PNEUMOMEDIASTINUM 22
699 PRODUCT PRESCRIBING ISSUE 22
700 SALMONELLOSIS 22
701 SECONDARY IMMUNODEFICIENCY 22
702 STAPHYLOCOCCAL SEPSIS 22
703 TOXOPLASMOSIS 22
704 URINE PROTEIN/CREATININE RATIO INCREASED 22
705 ACNE 21
706 AUTOIMMUNE HAEMOLYTIC ANAEMIA 21
707 CARDIAC FAILURE ACUTE 21
708 CEREBRAL ASPERGILLOSIS 21
709 CRYPTOCOCCAL CUTANEOUS INFECTION 21
710 DEVICE ISSUE 21
711 DRY EYE 21
712 ECZEMA 21
713 ENTEROCOLITIS 21
714 FACIAL PARALYSIS 21
715 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 21
716 HAEMATOTOXICITY 21
717 HYPOGLYCAEMIA 21
718 IMMUNODEFICIENCY 21
719 INTERNAL HAEMORRHAGE 21
720 JOINT STIFFNESS 21
721 KLEBSIELLA BACTERAEMIA 21
722 METASTATIC MALIGNANT MELANOMA 21
723 NEPHRITIS 21
724 OCULAR HYPERAEMIA 21
725 PAIN IN JAW 21
726 PNEUMONIA LEGIONELLA 21
727 POLYURIA 21
728 PRODUCT PRESCRIBING ERROR 21
729 PRODUCT STORAGE ERROR 21
730 PRODUCT SUBSTITUTION ISSUE 21
731 RHODOCOCCUS INFECTION 21
732 SKIN PAPILLOMA 21
733 WOUND 21
734 ACANTHAMOEBA INFECTION 20
735 ACUTE MYELOID LEUKAEMIA 20
736 AMENORRHOEA 20
737 ANHEDONIA 20
738 APHONIA 20
739 ARTHRITIS BACTERIAL 20
740 BLOOD CREATINE INCREASED 20
741 BLOOD IMMUNOGLOBULIN G DECREASED 20
742 BLOOD TEST ABNORMAL 20
743 BODY TEMPERATURE INCREASED 20
744 BRAIN FOG 20
745 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 20
746 DERMATOPHYTOSIS 20
747 DIABETES MELLITUS INADEQUATE CONTROL 20
748 DONOR SPECIFIC ANTIBODY PRESENT 20
749 ENDOPHTHALMITIS 20
750 FIBROMYALGIA 20
751 FUNCTIONAL GASTROINTESTINAL DISORDER 20
752 GUILLAIN-BARRE SYNDROME 20
753 HOT FLUSH 20
754 HYPERBILIRUBINAEMIA 20
755 HYPOALBUMINAEMIA 20
756 INSURANCE ISSUE 20
757 LIVER TRANSPLANT 20
758 LUNG TRANSPLANT 20
759 LYMPHOPROLIFERATIVE DISORDER 20
760 MALIGNANT NEOPLASM PROGRESSION 20
761 MATERNAL EXPOSURE TIMING UNSPECIFIED 20
762 MENTAL DISORDER 20
763 ODYNOPHAGIA 20
764 PAPILLOEDEMA 20
765 PSEUDOMONAL BACTERAEMIA 20
766 PULSELESS ELECTRICAL ACTIVITY 20
767 RASH PAPULAR 20
768 SUICIDAL IDEATION 20
769 TRANSPLANTATION COMPLICATION 20
770 TRICHOPHYTOSIS 20
771 URINOMA 20
772 ABDOMINAL ABSCESS 19
773 ACCIDENTAL OVERDOSE 19
774 ADRENAL INSUFFICIENCY 19
775 ASPIRATION 19
776 BILIARY OBSTRUCTION 19
777 CARDIOMYOPATHY 19
778 CARDIOTOXICITY 19
779 DIFFUSE ALVEOLAR DAMAGE 19
780 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 19
781 EPIDERMODYSPLASIA VERRUCIFORMIS 19
782 FEMUR FRACTURE 19
783 GASTRIC DISORDER 19
784 GASTROINTESTINAL MUCORMYCOSIS 19
785 HELICOBACTER INFECTION 19
786 HEPATITIS B 19
787 HISTIOCYTOSIS HAEMATOPHAGIC 19
788 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 19
789 HYPERSOMNIA 19
790 HYPOTONIA 19
791 INFECTION IN AN IMMUNOCOMPROMISED HOST 19
792 INJECTION SITE HAEMORRHAGE 19
793 LARGE INTESTINE INFECTION 19
794 MUSCLE ABSCESS 19
795 MYELODYSPLASTIC SYNDROME 19
796 NONSPECIFIC REACTION 19
797 OSMOTIC DEMYELINATION SYNDROME 19
798 PANCREATITIS HAEMORRHAGIC 19
799 PHOTOSENSITIVITY REACTION 19
800 PRE-ECLAMPSIA 19
801 PRESCRIBED UNDERDOSE 19
802 SKIN DISORDER 19
803 SYSTEMIC CANDIDA 19
804 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 19
805 THROMBOTIC THROMBOCYTOPENIC PURPURA 19
806 ALVEOLAR PROTEINOSIS 18
807 ANAL SQUAMOUS CELL CARCINOMA 18
808 BLOOD URIC ACID INCREASED 18
809 CATATONIA 18
810 CHOLELITHIASIS 18
811 COELIAC DISEASE 18
812 EAR INFECTION 18
813 FAILURE TO THRIVE 18
814 FUNGAEMIA 18
815 GASTROINTESTINAL TOXICITY 18
816 HEPATIC STEATOSIS 18
817 HERNIA 18
818 HYPERTRANSAMINASAEMIA 18
819 IGA NEPHROPATHY 18
820 INTESTINAL ISCHAEMIA 18
821 IRRITABILITY 18
822 MASS 18
823 NECROSIS 18
824 NECROTISING RETINITIS 18
825 PULMONARY ARTERIAL HYPERTENSION 18
826 PYODERMA GANGRENOSUM 18
827 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 18
828 RHABDOMYOLYSIS 18
829 STEROID DIABETES 18
830 STREPTOCOCCAL INFECTION 18
831 SUSPECTED OFF LABEL USE 18
832 TOXIC ENCEPHALOPATHY 18
833 URINARY INCONTINENCE 18
834 VENTRICULAR TACHYCARDIA 18
835 VIRAL LOAD 18
836 VITAMIN D DEFICIENCY 18
837 ACCIDENTAL EXPOSURE TO PRODUCT 17
838 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 17
839 ANGIOSARCOMA METASTATIC 17
840 AUTOIMMUNE HEPATITIS 17
841 BACILLUS INFECTION 17
842 BLOOD CREATINE PHOSPHOKINASE INCREASED 17
843 C3 GLOMERULOPATHY 17
844 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17
845 COMPLICATIONS OF TRANSPLANTED LUNG 17
846 CONVULSION 17
847 CORYNEBACTERIUM INFECTION 17
848 DEAFNESS 17
849 DISEASE COMPLICATION 17
850 GASTROINTESTINAL INFECTION 17
851 GLOMERULOSCLEROSIS 17
852 HEART RATE DECREASED 17
853 HYPERLIPIDAEMIA 17
854 INTENTIONAL OVERDOSE 17
855 MATERNAL EXPOSURE BEFORE PREGNANCY 17
856 METASTASES TO BONE 17
857 MICROSPORIDIA INFECTION 17
858 MYASTHENIA GRAVIS CRISIS 17
859 NECROTISING OESOPHAGITIS 17
860 OBESITY 17
861 RENAL GRAFT INFECTION 17
862 SENSORY LOSS 17
863 STATUS EPILEPTICUS 17
864 SUPRAVENTRICULAR TACHYCARDIA 17
865 TRANSPLANT 17
866 ABDOMINAL INFECTION 16
867 AMERICAN TRYPANOSOMIASIS 16
868 ANGIOPATHY 16
869 ATRIOVENTRICULAR BLOCK COMPLETE 16
870 AUTOIMMUNE DISORDER 16
871 BLINDNESS UNILATERAL 16
872 BLOOD CREATININE ABNORMAL 16
873 BRAIN DEATH 16
874 CORONARY ARTERY STENOSIS 16
875 DERMATOMYOSITIS 16
876 EYE IRRITATION 16
877 EYELID PTOSIS 16
878 FISTULA 16
879 GAMMA-GLUTAMYLTRANSFERASE INCREASED 16
880 GLAUCOMA 16
881 HYPOVOLAEMIC SHOCK 16
882 INCREASED APPETITE 16
883 INJECTION SITE SWELLING 16
884 INTERNATIONAL NORMALISED RATIO INCREASED 16
885 LABELLED DRUG-DRUG INTERACTION ISSUE 16
886 MALACOPLAKIA GASTROINTESTINAL 16
887 MALNUTRITION 16
888 MEDIASTINITIS 16
889 MENINGITIS BACTERIAL 16
890 MUSCLE ATROPHY 16
891 NEUROLOGICAL DECOMPENSATION 16
892 PERIOSTITIS 16
893 PROCTITIS 16
894 PROSTATE CANCER 16
895 RASH MACULAR 16
896 RAYNAUD^S PHENOMENON 16
897 RENAL TUBULAR ACIDOSIS 16
898 ROAD TRAFFIC ACCIDENT 16
899 SECRETION DISCHARGE 16
900 SEPTIC EMBOLUS 16
901 SPLENOMEGALY 16
902 TYPE 2 DIABETES MELLITUS 16
903 VIRAL HAEMORRHAGIC CYSTITIS 16
904 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 16
905 ACUTE CORONARY SYNDROME 15
906 AGGRESSION 15
907 APPENDICITIS 15
908 ATYPICAL MYCOBACTERIAL INFECTION 15
909 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 15
910 DELUSION 15
911 EMPHYSEMATOUS PYELONEPHRITIS 15
912 ENCEPHALOMALACIA 15
913 EYE INFECTION TOXOPLASMAL 15
914 GASTROENTERITIS ESCHERICHIA COLI 15
915 GASTROINTESTINAL ULCER 15
916 HERPES SIMPLEX OESOPHAGITIS 15
917 HERPES ZOSTER DISSEMINATED 15
918 HIDRADENITIS 15
919 HIP ARTHROPLASTY 15
920 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 15
921 HYPERTRIGLYCERIDAEMIA 15
922 IMMUNOGLOBULIN G4 RELATED DISEASE 15
923 INJECTION SITE ERYTHEMA 15
924 INJECTION SITE REACTION 15
925 IRRITABLE BOWEL SYNDROME 15
926 LIVER ABSCESS 15
927 LYMPHOCYTE COUNT DECREASED 15
928 LYMPHOMA 15
929 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 15
930 NORMOCYTIC ANAEMIA 15
931 OPTIC NEUROPATHY 15
932 PNEUMOCYSTIS JIROVECII INFECTION 15
933 RENAL CELL CARCINOMA 15
934 RENAL FUNCTION TEST ABNORMAL 15
935 SCAR 15
936 SKIN HAEMORRHAGE 15
937 SKIN MASS 15
938 SLEEP APNOEA SYNDROME 15
939 SMOOTH MUSCLE CELL NEOPLASM 15
940 SOFT TISSUE INFECTION 15
941 URINE OUTPUT DECREASED 15
942 VASOGENIC CEREBRAL OEDEMA 15
943 VENOOCCLUSIVE DISEASE 15
944 WOUND DEHISCENCE 15
945 ADENOVIRUS INTERSTITIAL NEPHRITIS 14
946 BLOOD IRON DECREASED 14
947 BLOOD PRESSURE ABNORMAL 14
948 BRADYARRHYTHMIA 14
949 BREAST CANCER 14
950 BURSITIS 14
951 CARDIAC DYSFUNCTION 14
952 CHROMATURIA 14
953 COMPLICATIONS OF TRANSPLANTED HEART 14
954 CYTOMEGALOVIRUS GASTROENTERITIS 14
955 CYTOMEGALOVIRUS SYNDROME 14
956 DRUG LEVEL FLUCTUATING 14
957 EYE SWELLING 14
958 FIBROSIS 14
959 FOLLICULITIS 14
960 FOOD POISONING 14
961 FUNGAL SEPSIS 14
962 GENE MUTATION 14
963 GLUCOSE TOLERANCE IMPAIRED 14
964 HEART TRANSPLANT 14
965 HEPATITIS ACUTE 14
966 HYDROCEPHALUS 14
967 ILEAL ULCER 14
968 INFLAMMATORY MARKER INCREASED 14
969 INFUSION SITE ERYTHEMA 14
970 INTRAOCULAR PRESSURE INCREASED 14
971 LARGE INTESTINE POLYP 14
972 METASTATIC SQUAMOUS CELL CARCINOMA 14
973 NASAL CAVITY CANCER 14
974 NEOPLASM PROGRESSION 14
975 NEUROLOGICAL SYMPTOM 14
976 ORTHOSTATIC HYPOTENSION 14
977 PNEUMONIA PNEUMOCOCCAL 14
978 PULMONARY FUNCTION TEST DECREASED 14
979 PULMONARY TUBERCULOSIS 14
980 RENAL TUBULAR DYSFUNCTION 14
981 RIB FRACTURE 14
982 SEASONAL ALLERGY 14
983 SERRATIA INFECTION 14
984 TENDERNESS 14
985 WALKING AID USER 14
986 ACARODERMATITIS 13
987 ACUTE SINUSITIS 13
988 ANAL HAEMORRHAGE 13
989 BONE PAIN 13
990 CD4 LYMPHOCYTES DECREASED 13
991 CENTRAL NERVOUS SYSTEM ABSCESS 13
992 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 13
993 CEREBRAL ATROPHY 13
994 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 13
995 COCCIDIOIDOMYCOSIS 13
996 DIVERTICULUM 13
997 DYSLIPIDAEMIA 13
998 DYSSTASIA 13
999 ELECTROCARDIOGRAM QT PROLONGED 13